Abstract 5057: Enhancing clinical applications by evaluation of sensitivity and specificity in whole exome sequencing

Abstract The cost-effectiveness of whole exome sequencing (WES) remains debated, primarily due to variability in variant calls. Evaluating the sensitivity and specificity of WES results may clarify this issue. WES was performed by three companies (AA, BB, and CC) using reference standards composed of DNA from Hydatidiform mole and individual blood at various ratios. Sensitivity was assessed by the detection rate of null-homozygote (N-H) alleles at expected variant allelic fractions, while false positive (FP) errors were counted for unexpected alleles. Sensitivity was approximately 20% for in-house results from BB and CC and around 5% for AA. Dragen analyses identified 1.34 to 1.71 times more variants, detecting over 96% of in-house variants, with sensitivity for common variants increasing to 5%. In-house FP errors varied significantly among companies (up to 13.97 times), while Dragen analyses minimized this variation. Despite Dragen showing higher FP errors for BB and CC, the increased sensitivity highlights the importance of effective bioinformatic conditions. We also assessed the potential effects of target enrichment and proposed optimal cutoff values for read depth and variant allele fraction in WES. Optimizing bioinformatic analysis based on sensitivity and specificity from reference standards can enhance variant detection and improve the clinical utility of WES. Citation Format: Chunghwan Hong, Youngbeen Moon, Hye Won Choi, Eun-Kyung Kang, Seo-Hyeon Ye, Jong-Kwang Kim, Young-Ho Kim, Hyeri Cho, Hana Choi, Dong-eun Lee, Yongdoo Choi, Tae-Min Kim, Seong Gu Heo, Namshik Han, Kyeong-Man Hong. Enhancing clinical applications by evaluation of sensitivity and specificity in whole exome sequencing [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 5057.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-04-21
DOI
https://doi.org/10.1158/1538-7445.am2025-5057
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 5057: Enhancing clinical applications by evaluation of sensitivity and specificity in whole exome sequencing

Seong Gu Heo, Yongdoo Choi, Youngbeen Moon, Jong-Kwang Kim et al.
1 links
Cancer Research
Genomics and Rare Diseases
article

Abstract 5057: Enhancing clinical applications by evaluation of sensitivity and specificity in whole exome sequencing

Seong Gu Heo, Yongdoo Choi, Youngbeen Moon, Jong-Kwang Kim, Hyewon Choi, Namshik Han, Dong-eun Lee, Hong Chen, Young Ho Kim, Tae‐Min Kim, Hyeri Cho, Hana Choi, Kyeong-Man Hong, Eun-Kyung Kang, Seo-Hyeon Ye
article en

Abstract

Abstract The cost-effectiveness of whole exome sequencing (WES) remains debated, primarily due to variability in variant calls. Evaluating the sensitivity and specificity of WES results may clarify this issue. WES was performed by three companies (AA, BB, and CC) using reference standards composed of DNA from Hydatidiform mole and individual blood at various ratios. Sensitivity was assessed by the detection rate of null-homozygote (N-H) alleles at expected variant allelic fractions, while false positive (FP) errors were counted for unexpected alleles. Sensitivity was approximately 20% for in-house results from BB and CC and around 5% for AA. Dragen analyses identified 1.34 to 1.71 times more variants, detecting over 96% of in-house variants, with sensitivity for common variants increasing to 5%. In-house FP errors varied significantly among companies (up to 13.97 times), while Dragen analyses minimized this variation. Despite Dragen showing higher FP errors for BB and CC, the increased sensitivity highlights the importance of effective bioinformatic conditions. We also assessed the potential effects of target enrichment and proposed optimal cutoff values for read depth and variant allele fraction in WES. Optimizing bioinformatic analysis based on sensitivity and specificity from reference standards can enhance variant detection and improve the clinical utility of WES. Citation Format: Chunghwan Hong, Youngbeen Moon, Hye Won Choi, Eun-Kyung Kang, Seo-Hyeon Ye, Jong-Kwang Kim, Young-Ho Kim, Hyeri Cho, Hana Choi, Dong-eun Lee, Yongdoo Choi, Tae-Min Kim, Seong Gu Heo, Namshik Han, Kyeong-Man Hong. Enhancing clinical applications by evaluation of sensitivity and specificity in whole exome sequencing [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 5057.

Cancer ResearchVol. 85(8_Supplement_1)
University of Cambridge (GB), Dana-Farber Cancer Institute (US), National Cancer Center (KR), Catholic University of Korea (KR)
Openalex Percentile: Top 90%
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.